Last reviewed · How we verify

NCT03077633

Cerclage for Twins With Short Cervix

Withdrawn Phase 2, PHASE3 Last updated 21 March 2018
What this trial tests

Phase 2, PHASE3 trial testing Cervical Cerclage placement in Preterm Birth. Withdrawn.

Timeline
1 October 2017
Primary endpoint
17 January 2018
17 January 2018

Quick facts

Lead sponsorPediatrix
PhasePhase 2, PHASE3
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Start date1 October 2017
Primary completion17 January 2018
Estimated completion17 January 2018

Drugs / interventions tested

Conditions studied

Sponsor

Pediatrix — full company profile →

Who can join

18 and older, any sex, with Preterm Birth or Preterm Labor With Preterm Delivery, Unspecified Trimester, Fetus 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective randomized control trial that will compare cervical cerclage plus vaginal progesterone to vaginal progesterone along in twin pregnancies complicate by a short cervix (\</= 15.0mm) between 16w0d to 25w6d.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

Other Pediatrix trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03077633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing